Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Cervical Cancer, August 2019

Free Subscription


Abstracts

Retrieve all available abstracts of the following 198 articles:
HTML format


 

Single Articles

  1. ENGLISH PMB
    Eradicating cervical cancer is unlikely.
    BMJ. 2019;366:l4953.
    Abstract    



  2. BRALSFORD KJ, Jamieson E
    Following Australia's lead to eradicate cervical cancer.
    BMJ. 2019;366:l4955.
    Abstract    



  3. TURIN TC, Ferdous M, Rumana N
    Cervical cancer screening among immigrant women: Framing the barriers through solution oriented lens.
    Eur J Oncol Nurs. 2019 Jul 10. pii: S1462-3889(19)30082.
    Abstract    



  4. DEVINE C, Viswanathan C, Faria S, Marcal L, et al
    Imaging and Staging of Cervical Cancer.
    Semin Ultrasound CT MR. 2019;40:280-286.
    Abstract    

    Abstract available

  5. CAO W, Yao X, Cen D, Zhi Y, et al
    Prognostic role of pretreatment thrombocytosis on survival in patients with cervical cancer: a systematic review and meta-analysis.
    World J Surg Oncol. 2019;17:132.
    Abstract    

    Abstract available

  6. WANG H, Jiang C, Bao K, Xu C, et al
    Recognition and Clinical Diagnosis of Cervical Cancer Cells Based on our Improved Lightweight Deep Network for Pathological Image.
    J Med Syst. 2019;43:301.
    Abstract    

    Abstract available

  7. BUIST DSM, Tiro JA, Thayer C, Beatty T, et al
    Improving the promise of embedded pragmatic trials: Surmountable barriers encountered in an evaluation of home-based HPV self-sampling to increase cervical cancer screening in overdue women.
    Contemp Clin Trials Commun. 2019;15:100413.
    Abstract    

    Abstract available

  8. YU M, Xu B, Yang H, Xue S, et al
    MicroRNA-218 regulates the chemo-sensitivity of cervical cancer cells through targeting survivin.
    Cancer Manag Res. 2019;11:6511-6519.
    Abstract    

    Abstract available

  9. KUMAR T, Schernberg A, Busato F, Laurans M, et al
    Correlation between pelvic bone marrow radiation dose and acute hematological toxicity in cervical cancer patients treated with concurrent chemoradiation.
    Cancer Manag Res. 2019;11:6285-6297.
    Abstract    

    Abstract available

  10. WANG R, Li Y, Du P, Zhang X, et al
    Hypomethylation of the lncRNA SOX21-AS1 has clinical prognostic value in cervical cancer.
    Life Sci. 2019 Jul 29:116708. doi: 10.1016/j.lfs.2019.116708.
    Abstract    

    Abstract available

  11. ZHUANDI G, Xiaoyun S, Juan Y, Luju L, et al
    Receptor Binding Inhibitor Suppresses Carcinogenesis of Cervical Cancer by Depressing Levels of FSHR and ERbeta in mice.
    Anticancer Agents Med Chem. 2019 Jul 31. pii: ACAMC-EPUB-100075.
    Abstract    

    Abstract available

  12. KUNDROD KA, Smith CA, Hunt B, Schwarz RA, et al
    Advances in technologies for cervical cancer detection in low-resource settings.
    Expert Rev Mol Diagn. 2019 Aug 1:1-19. doi: 10.1080/14737159.2019.1648213.
    Abstract    

    Abstract available

  13. SUNDARAM MK, Raina R, Afroze N, Bajbouj K, et al
    Quercetin modulates signaling pathways and induces apoptosis in cervical cancer cells.
    Biosci Rep. 2019 Jul 31. pii: BSR20190720. doi: 10.1042/BSR20190720.
    Abstract    

    Abstract available

  14. BRANDT T, Wubneh SB, Handebo S, Debalkie G, et al
    Genital self-sampling for HPV-based cervical cancer screening: a qualitative study of preferences and barriers in rural Ethiopia.
    BMC Public Health. 2019;19:1026.
    Abstract    

    Abstract available

  15. TONHAJZEROVA I, Olexova LB, Jurko A Jr, Spronck B, et al
    Novel Biomarkers of Early Atherosclerotic Changes for Personalised Prevention of Cardiovascular Disease in Cervical Cancer and Human Papillomavirus Infection.
    Int J Mol Sci. 2019;20.
    Abstract    

    Abstract available

  16. SANGRAJRANG S, Laowahutanont P, Wongsena M, Muwonge R, et al
    Human papillomavirus (HPV) DNA and mRNA primary cervical cancer screening: Evaluation and triaging options for HPV-positive women.
    J Med Screen. 2019 Jul 31:969141319865922. doi: 10.1177/0969141319865922.
    Abstract    



  17. DE OLIVEIRA PEREIRA F, Pereira Mota A, Azevedo Aredes M, Villaca Chaves G, et al
    Association between Scored Patient-Generated Subjective Global Assessment and Skeletal Muscle Determined by Computed Tomography in Patients with Cervical Cancer.
    Nutr Cancer. 2019 Jul 31:1-7. doi: 10.1080/01635581.2019.1645866.
    Abstract    

    Abstract available

  18. NAGHASHI N, Ghorbian S
    Clinical important dysregulation of long non-coding RNA CCHE1 and HULC in carcinogenesis of cervical cancer.
    Mol Biol Rep. 2019 Jul 30. pii: 10.1007/s11033-019-04996.
    Abstract    

    Abstract available

  19. CHAO X, Li L, Wu M, Ma S, et al
    Efficacy of different surgical approaches in the clinical and survival outcomes of patients with early-stage cervical cancer: protocol of a phase III multicentre randomised controlled trial in China.
    BMJ Open. 2019;9:e029055.
    Abstract    

    Abstract available

  20. CHEN ZH, Jing YJ, Yu JB, Jin ZS, et al
    ESRP1 Induces Cervical Cancer Cell G1-Phase Arrest Via Regulating Cyclin A2 mRNA Stability.
    Int J Mol Sci. 2019;20.
    Abstract    

    Abstract available

  21. MENON S, Rodolfo R, Akudibillah G, Dusabimana A, et al
    Effects of malaria/helminthic coinfections on cervical cancer progression among sub Saharan African women on highly active antiretroviral therapy: A scoping review.
    Gynecol Oncol Rep. 2019;29:64-69.
    Abstract    

    Abstract available

  22. SHAH S, Kalal BS
    Oxidative stress in cervical cancer and its response to chemoradiation.
    Turk J Obstet Gynecol. 2019;16:124-128.
    Abstract    

    Abstract available

  23. HALDORSEN IS, Lura N, Blaakaer J, Fischerova D, et al
    What Is the Role of Imaging at Primary Diagnostic Work-Up in Uterine Cervical Cancer?
    Curr Oncol Rep. 2019;21:77.
    Abstract    

    Abstract available

  24. CHAUHAN N, Maher DM, Yallapu MM, B Hafeez B, et al
    A triphenylethylene nonsteroidal SERM attenuates cervical cancer growth.
    Sci Rep. 2019;9:10917.
    Abstract    

    Abstract available

  25. GHASEMI F, Shafiee M, Banikazemi Z, Pourhanifeh MH, et al
    Curcumin inhibits NF-kB and Wnt/beta-catenin pathways in cervical cancer cells.
    Pathol Res Pract. 2019 Jul 23:152556. doi: 10.1016/j.prp.2019.152556.
    Abstract    

    Abstract available

  26. OCHOA E, Carrillo GM, Sanabria D
    Finding myself as a cervical cancer survivor: A qualitative study.
    Eur J Oncol Nurs. 2019;41:143-148.
    Abstract    

    Abstract available

  27. OKAMOTO H, Murakami N, Isohashi F, Kasamatsu T, et al
    Dummy-run for standardizing plan quality of intensity-modulated radiotherapy for postoperative uterine cervical cancer: Japan Clinical Oncology Group study (JCOG1402).
    Radiat Oncol. 2019;14:133.
    Abstract    

    Abstract available

  28. TAPERA O, Dreyer G, Kadzatsa W, Nyakabau AM, et al
    Determinants of access and utilization of cervical cancer treatment and palliative care services in Harare, Zimbabwe.
    BMC Public Health. 2019;19:1018.
    Abstract    

    Abstract available

  29. YE T, Yao H, Xu Y, Zhao X, et al
    Role of Smac, survivin, XIAP, and Omi/HtrA2 proteins in determining the chemotherapeutic response of patients with cervical cancer treated with neoadjuvant chemotherapy.
    Cancer Biomark. 2019 Jul 16. pii: CBM182165. doi: 10.3233/CBM-182165.
    Abstract    

    Abstract available

  30. PAN L, Yan G, Chen W, Sun L, et al
    Distribution of circulating tumor cell phenotype in early cervical cancer.
    Cancer Manag Res. 2019;11:5531-5536.
    Abstract    

    Abstract available

  31. YAN DD, Tang Q, Chen JH, Tu YQ, et al
    Prognostic value of the 2018 FIGO staging system for cervical cancer patients with surgical risk factors.
    Cancer Manag Res. 2019;11:5473-5480.
    Abstract    

    Abstract available

  32. WU J, Luo M, Duan Z, Jia Y, et al
    WHSC1 acts as a prognostic indicator and functions as an oncogene in cervical cancer.
    Onco Targets Ther. 2019;12:4683-4690.
    Abstract    

    Abstract available

  33. DAI F, Chen G, Wang Y, Zhang L, et al
    Identification of candidate biomarkers correlated with the diagnosis and prognosis of cervical cancer via integrated bioinformatics analysis.
    Onco Targets Ther. 2019;12:4517-4532.
    Abstract    

    Abstract available

  34. LIU L, Chen Y, Zhang Q, Li C, et al
    Silencing of KCNA1 suppresses the cervical cancer development via mitochondria damage.
    Channels (Austin). 2019;13:321-330.
    Abstract    

    Abstract available

  35. NAGENDIRAM A, Bougher H, Banks J, Hall L, et al
    Australian women's self-perceived barriers to participation in cervical cancer screening: a systematic review.
    Health Promot J Austr. 2019 Jul 28. doi: 10.1002.
    Abstract    

    Abstract available

  36. POMEL C, Lecuru F, Leblanc E, Mathevet P, et al
    [Minimal invasive surgery for early stage cervical cancer. Recommendations from the GINECO surgeon's group].
    Bull Cancer. 2019 Jul 25. pii: S0007-4551(19)30258.
    Abstract    



  37. XIE K, Sun H, Gao L, Sui J, et al
    A study on the correlation between radiation field size and gamma index passing rate for MatriXX.
    Medicine (Baltimore). 2019;98:e16536.
    Abstract    

    Abstract available

  38. FITZPATRICK MB, El-Khatib Z, Katzenstein D, Pinsky BA, et al
    Community-based self-collected human papillomavirus screening in rural Zimbabwe.
    BMC Public Health. 2019;19.
    Abstract    

    Abstract available

  39. GUPTA SM, Mania-Pramanik J
    Molecular mechanisms in progression of HPV-associated cervical carcinogenesis.
    J Biomed Sci. 2019;26:28.
    Abstract    

    Abstract available

  40. KUO CY, Schelz Z, Toth B, Vasas A, et al
    Investigation of natural phenanthrenes and the antiproliferative potential of juncusol in cervical cancer cell lines.
    Phytomedicine. 2019;58:152770.
    Abstract    

    Abstract available

  41. MATHOULIN-PELISSIER S, Penel N
    [Cancer screening words].
    Bull Cancer. 2019;106.
    Abstract    



  42. CHEN W, Chen X, Wang Y, Liu T, et al
    Construction and Analysis of lncRNA-Mediated ceRNA Network in Cervical Squamous Cell Carcinoma by Weighted Gene Co-Expression Network Analysis.
    Med Sci Monit. 2019;25:2609-2622.
    Abstract    

    Abstract available

  43. RIBEIRO B, Silva R, Dias R, Patricio V, et al
    Carcinosarcoma of the uterine cervix: a rare pathological finding originating from mesonephric remnants.
    BMJ Case Rep. 2019;12.
    Abstract    

    Abstract available

  44. POOMTAVORN Y, Tanprasertkul C, Sammor A, Suwannarurk K, et al
    Predictors of Absent High-grade Cervical Intraepithelial Neoplasia (CIN) in Loop Electrosurgical Excision Procedure Specimens of Patients with Colposcopic Directed Biopsy-Confirmed High-Grade CIN
    Asian Pac J Cancer Prev. 2019;20:849-854.
    Abstract    

    Abstract available

  45. SHARMA B, Gupta M, Sharma R, Gupta A, et al
    Four percent formalin application for the management of radiation proctitis in carcinoma cervix patients: An effective, safe, and economical practice.
    J Cancer Res Ther. 2019;15:92-95.
    Abstract    

    Abstract available

  46. YANG M, Wang H, Wang Z, Han Z, et al
    A Nd(3+) sensitized upconversion nanosystem with dual photosensitizers for improving photodynamic therapy efficacy.
    Biomater Sci. 2019;7:1686-1695.
    Abstract    

    Abstract available

  47. BALDUR-FELSKOV B, Mwaiselage J, Faber MT, Kjaerem M, et al
    Factors associated with a cervical high-grade lesion on cytology or a positive visual inspection with acetic acid among more than 3300 Tanzanian women.
    Trop Med Int Health. 2019;24:229-237.
    Abstract    

    Abstract available

  48. KARADAG ARLI S, Bakan AB, Aslan G
    Distribution of cervical and breast cancer risk factors in women and their screening behaviours.
    Eur J Cancer Care (Engl). 2019;28:e12960.
    Abstract    

    Abstract available

  49. WANG R, Tao X, Wu X, Jiang H, et al
    The Number of Removed Pelvic Lymph Nodes as a Prognostic Marker in FIGO Stage IB1 Cervical Cancer with Negative Lymph Nodes.
    J Minim Invasive Gynecol. 2019 Aug 5. pii: S1553-4650(19)30335.
    Abstract    

    Abstract available

  50. DIETL A, Klar M, Aumann K
    Minimally invasive surgery for early-stage cervical cancer: is the uterine manipulator a risk factor?
    Am J Obstet Gynecol. 2019 Aug 5. pii: S0002-9378(19)30950.
    Abstract    



  51. DING D, Jiang H, Nie J, Liu X, et al
    Concurrent Learning Curves of 3-Dimensional and Robotic-Assisted Laparoscopic Radical Hysterectomy for Early-Stage Cervical Cancer Using 2-Dimensional Laparoscopic Radical Hysterectomy as a Benchmark: A Single Surgeon's Experience.
    Med Sci Monit. 2019;25:5903-5919.
    Abstract    

    Abstract available

  52. KUCZBORSKA K, Kacperczyk-Bartnik J, Wolska M, Pluta M, et al
    Secondary cervical cancer prevention in routine prenatal care - coverage, results and lessons for the future.
    Ginekol Pol. 2019;90:396-402.
    Abstract    

    Abstract available

  53. FENG Y, Qu L, Wang X, Liu C, et al
    LINC01133 promotes the progression of cervical cancer by sponging miR-4784 to up-regulate AHDC1.
    Cancer Biol Ther. 2019 Aug 7:1-9. doi: 10.1080/15384047.2019.1647058.
    Abstract    

    Abstract available

  54. XIANG M, Kidd EA
    Benefit of Cisplatin With Definitive Radiotherapy in Older Women With Cervical Cancer.
    J Natl Compr Canc Netw. 2019;17:969-975.
    Abstract    

    Abstract available

  55. KHAN F, Pandey P, Upadhyay TK, Jafri A, et al
    Anticancerous effect of rutin against HPV- C33A cervical cancer cells via G0/G1 cell cycle arrest and apoptotic induction.
    Endocr Metab Immune Disord Drug Targets. 2019 Aug 6. pii: EMIDDT-EPUB-100144.
    Abstract    

    Abstract available

  56. BEHAREE N, Shi Z, Wu D, Wang J, et al
    Diagnosis and treatment of cervical cancer in pregnant women.
    Cancer Med. 2019 Aug 6. doi: 10.1002/cam4.2435.
    Abstract    

    Abstract available

  57. NKFUSAI NC, Cumber SN, Anchang-Kimbi JK, Nji KE, et al
    Assessment of the current state of knowledge and risk factors of cervical cancer among women in the Buea Health District, Cameroon.
    Pan Afr Med J. 2019;33:38.
    Abstract    

    Abstract available

  58. NURANNA L, Fahrudin A
    Survival Rate of Cervical Cancer in National Referral Hospital in 2012 - 2014.
    Acta Med Indones. 2019;51:145-150.
    Abstract    

    Abstract available

  59. HOCKEL M, Wolf B, Schmidt K, Mende M, et al
    Surgical resection based on ontogenetic cancer field theory for cervical cancer: mature results from a single-centre, prospective, observational, cohort study.
    Lancet Oncol. 2019 Aug 2. pii: S1470-2045(19)30389.
    Abstract    

    Abstract available

  60. RASPAGLIESI F, Bogani G
    Radical surgery for cervical cancer.
    Lancet Oncol. 2019 Aug 2. pii: S1470-2045(19)30409.
    Abstract    



  61. BAO Z, Wang D, Chen S, Chen M, et al
    Optimal dose limitation strategy for bone marrow sparing in intensity-modulated radiotherapy of cervical cancer.
    Radiat Oncol. 2019;14:118.
    Abstract    

    Abstract available

  62. ATHANASIOU A, Veroniki AA, Efthimiou O, Kalliala I, et al
    Comparative efficacy and complication rates after local treatment for cervical intraepithelial neoplasia and stage 1a1 cervical cancer: protocol for a systematic review and network meta-analysis from the CIRCLE Group.
    BMJ Open. 2019;9:e028008.
    Abstract    

    Abstract available

  63. SOUSA H, Tavares A, Campos C, Marinho-Dias J, et al
    High-Risk human papillomavirus genotype distribution in the Northern region of Portugal: Data from regional cervical cancer screening program.
    Papillomavirus Res. 2019 Aug 1:100179. doi: 10.1016/j.pvr.2019.100179.
    Abstract    

    Abstract available

  64. KUSHALNAGAR P, Engelman A, Simons AN
    Deaf Women's Health: Adherence to Breast and Cervical Cancer Screening Recommendations.
    Am J Prev Med. 2019 Aug 1. pii: S0749-3797(19)30211.
    Abstract    

    Abstract available

  65. MENDOZA-ALMANZA G, Rocha-Zavaleta L, Aguilar-Zacarias C, Ayala-Lujan J, et al
    Bacillus thuringiensis toxins are cytotoxic to cervical cancer (HeLa) but not to breast cancer (MCF7) cells.
    Curr Pharm Biotechnol. 2019 Aug 2. pii: CPB-EPUB-100111.
    Abstract    

    Abstract available

  66. DUAN LF, Du H, Xiao AM, Wang C, et al
    [Relationship between cervical lesions and the type-specific viral load of high risk HPV reflected by the Ct value of Cobas 4800 HPV system].
    Zhonghua Fu Chan Ke Za Zhi. 2019;54:458-463.
    Abstract    

    Abstract available

  67. HORN LC, Hohn AK, Stark S, Einenkel J, et al
    Endocervical adenocarcinoma in situ (AIS) with ovarian and pulmonary involvement: report of a case and review of the literature suggesting a "seed and soil hypothesis".
    J Cancer Res Clin Oncol. 2019;145:2061-2069.
    Abstract    

    Abstract available

  68. MISHRA DK, Yadava PK
    Centrality of telomerase in cellular life.
    Indian J Med Res. 2019;149:317-318.
    Abstract    



  69. TSYGANOV MM, Pevzner AM, Ibragimova MK, Deryusheva IV, et al
    Human papillomavirus and lung cancer: an overview and a meta-analysis.
    J Cancer Res Clin Oncol. 2019 Jun 24. pii: 10.1007/s00432-019-02960.
    Abstract    

    Abstract available

  70. VENTURELLA G, Saporita P, Gargano ML
    The Potential Role of Medicinal Mushrooms in the Prevention and Treatment of Gynecological Cancers: A Review.
    Int J Med Mushrooms. 2019;21:225-235.
    Abstract    

    Abstract available

  71. BONIN L, Devouassoux-Shisheboran M, Golfier F
    Clinicopathological characteristics of patients with mucinous adenocarcinoma of the uterine cervix: A retrospective study of 21 cases.
    J Gynecol Obstet Hum Reprod. 2019;48:319-327.
    Abstract    

    Abstract available

  72. TUNG WC, Granner M, Lu M, Sohn J, et al
    Demographics, self-efficacy, benefits/barriers, stages of adopting pap testing among Korean American women.
    J Obstet Gynaecol. 2019;39:510-515.
    Abstract    

    Abstract available

  73. BONIN L, Devouassoux-Shisheboran M, Golfier F
    [Focus on mucinous adenocarcinoma of the uterine cervix].
    Gynecol Obstet Fertil Senol. 2019;47:352-361.
    Abstract    

    Abstract available

  74. LI L, Ma S, Tan X, Zhong S, et al
    The Urodynamics and Survival Outcomes of Different Methods of Dissecting the Inferior Hypogastric Plexus in Laparoscopic Nerve-Sparing Radical Hysterectomy of Type C: A Randomized Controlled Study.
    Ann Surg Oncol. 2019;26:1560-1568.
    Abstract    

    Abstract available

  75. NAHAR F, Hossain MA, Paul SK, Ahmed MU, et al
    Molecular Diagnosis of Human Papilloma Virus by PCR.
    Mymensingh Med J. 2019;28:175-181.
    Abstract    

    Abstract available

  76. BEREK JS, Matsuo K, Grubbs BH, Gaffney DK, et al
    Multidisciplinary perspectives on newly revised 2018 FIGO staging of cancer of the cervix uteri.
    J Gynecol Oncol. 2019;30:e40.
    Abstract    



  77. MIN KJ, Kwon SH, Kim K, Kim S, et al
    Clinical guideline for 9-valent HPV vaccine: Korean Society of Gynecologic Oncology Guideline.
    J Gynecol Oncol. 2019;30:e31.
    Abstract    

    Abstract available

  78. TERMRUNGRUANGLERT W, Khemapech N, Tantitamit T, Havanond P, et al
    Cost effectiveness analysis of HPV primary screening and dual stain cytology triage compared with cervical cytology.
    J Gynecol Oncol. 2019;30:e17.
    Abstract    

    Abstract available

  79. SCHAD MD, Moore J, Camacho F, Anderson RT, et al
    Predictors of quality of care and survival in a three-state cohort of locally advanced cervical cancer patients and development of a predictive model to identify women at risk of incomplete treatment.
    Medicine (Baltimore). 2019;98:e16874.
    Abstract    

    Abstract available

  80. ERENOGLU R, Yaman Sozbir S
    The Effect of Health Education Given to Syrian Refugee Women in Their Own Language on Awareness of Breast and Cervical Cancer, in Turkey: a Randomized Controlled Trial.
    J Cancer Educ. 2019 Aug 14. pii: 10.1007/s13187-019-01604.
    Abstract    

    Abstract available

  81. OBRZUT B, Kusy M, Semczuk A, Obrzut M, et al
    Prediction of 10-year Overall Survival in Patients with Operable Cervical Cancer using a Probabilistic Neural Network.
    J Cancer. 2019;10:4189-4195.
    Abstract    

    Abstract available

  82. BANTE SA, Getie SA, Getu AA, Mulatu K, et al
    Uptake of pre-cervical cancer screening and associated factors among reproductive age women in Debre Markos town, Northwest Ethiopia, 2017.
    BMC Public Health. 2019;19:1102.
    Abstract    

    Abstract available

  83. MAREMBO T, Dube Mandishora R, Borok M
    Use of Multiplex Polymerase Chain Reaction for Detection of High-Risk Human Papillomavirus Genotypes in Women Attending Routine Cervical Cancer Screening in Harare.
    Intervirology. 2019 Aug 14:1-6. doi: 10.1159/000502206.
    Abstract    

    Abstract available

  84. VENANCIO PA, Consolaro MEL, Derchain SF, Boccardo E, et al
    Indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase expression in HPV infection, SILs, and cervical cancer.
    Cancer Cytopathol. 2019 Aug 14. doi: 10.1002/cncy.22172.
    Abstract    

    Abstract available

  85. CHOI YJ, Lee HY, An S, Yoon YJ, et al
    Predictors of Cervical Cancer Screening Awareness and Literacy Among Korean-American Women.
    J Racial Ethn Health Disparities. 2019 Aug 13. pii: 10.1007/s40615-019-00628.
    Abstract    

    Abstract available

  86. HUANG L, Gan X, He L, Wang L, et al
    Silencing of long non-coding RNA NCK1-AS1 inhibits cell proliferation and migration via inhibition of microRNA-134 in cervical cancer.
    Exp Ther Med. 2019;18:2314-2322.
    Abstract    

    Abstract available

  87. ZHENG J, Yu J, Yang M, Tang L, et al
    Gefitinib suppresses cervical cancer progression by inhibiting cell cycle progression and epithelial-mesenchymal transition.
    Exp Ther Med. 2019;18:1823-1830.
    Abstract    

    Abstract available

  88. MURUGESAN K, Koroth J, Srinivasan PP, Singh A, et al
    Effects of green synthesised silver nanoparticles (ST06-AgNPs) using curcumin derivative (ST06) on human cervical cancer cells (HeLa) in vitro and EAC tumor bearing mice models.
    Int J Nanomedicine. 2019;14:5257-5270.
    Abstract    

    Abstract available

  89. LV M, Ou R, Zhang Q, Lin F, et al
    MicroRNA-664 suppresses the growth of cervical cancer cells via targeting c-Kit.
    Drug Des Devel Ther. 2019;13:2371-2379.
    Abstract    

    Abstract available

  90. ZENG YT, Liu XF, Yang WT, Zheng PS, et al
    REX1 promotes EMT-induced cell metastasis by activating the JAK2/STAT3-signaling pathway by targeting SOCS1 in cervical cancer.
    Oncogene. 2019 Aug 13. pii: 10.1038/s41388-019-0906.
    Abstract    

    Abstract available

  91. LI H, Zhou CK, Song J, Zhang WY, et al
    Curative efficacy of low frequency electrical stimulation in preventing urinary retention after cervical cancer operation.
    World J Surg Oncol. 2019;17:141.
    Abstract    

    Abstract available

  92. YIN S, Yang M, Li X, Zhang K, et al
    Peripheral blood circulating microRNA-4636/-143 for the prognosis of cervical cancer.
    J Cell Biochem. 2019 Aug 12. doi: 10.1002/jcb.29305.
    Abstract    

    Abstract available

  93. VAN ARSDALE A, Patterson NE, Maggi EC, Agoni L, et al
    Insertional oncogenesis by HPV70 revealed by multiple genomic analyses in a clinically HPV-negative cervical cancer.
    Genes Chromosomes Cancer. 2019 Aug 13. doi: 10.1002/gcc.22799.
    Abstract    

    Abstract available

  94. IMANO N, Wadasaki K, Nishibuchi I, Nagata Y, et al
    Comparison of clinical outcome between computed tomography-based image-guided brachytherapy and two-dimensional-based brachytherapy for cervical cancer.
    Gynecol Oncol Rep. 2019;29:79-82.
    Abstract    

    Abstract available

  95. DU P, Lai YH, Yao DS, Chen JY, et al
    Downregulation of microRNA-1246 inhibits tumor growth and promotes apoptosis of cervical cancer cells by targeting thrombospondin-2.
    Oncol Lett. 2019;18:2491-2499.
    Abstract    

    Abstract available

  96. KARES S, Veijalainen O, Kholova I, Tirkkonen M, et al
    HIGH RISK HPV testing as the primary screening method in an organised regional screening programme for cervical cancer: The value of HPV16 and HPV18 genotyping?
    APMIS. 2019 Aug 12. doi: 10.1111/apm.12990.
    Abstract    

    Abstract available

  97. WANG Y, Zuo A, Huang X, Ying Y, et al
    Docetaxel-Loaded PAMAM-Based Poly (gamma-benzyl-L-glutamate)-b- D -alpha - Tocopheryl Polyethylene Glycol 1000 Succinate Nanoparticles in Human Breast Cancer And Human Cervical Cancer therapy.
    J Microencapsul. 2019 Aug 12:1-33. doi: 10.1080/02652048.2019.1654002.
    Abstract    

    Abstract available

  98. PAIK ES, Lim MC, Kim MH, Kim YH, et al
    Prognostic Model for Survival and Recurrence in Patients with Early Stage Cervical Cancer: A Korean Gynecologic Oncology Group Study (KGOG 1028).
    Cancer Res Treat. 2019 Aug 5. pii: crt.2019.124. doi: 10.4143/crt.2019.
    Abstract    

    Abstract available

  99. BLACK E, Hyslop F, Richmond R
    Barriers and facilitators to uptake of cervical cancer screening among women in Uganda: a systematic review.
    BMC Womens Health. 2019;19:108.
    Abstract    

    Abstract available

  100. ALMEIDA AM, Queiroz JA, Sousa F, Sousa A, et al
    Cervical cancer and HPV infection: ongoing therapeutic research to counteract the action of E6 and E7 oncoproteins.
    Drug Discov Today. 2019 Aug 6. pii: S1359-6446(19)30310.
    Abstract    

    Abstract available

  101. BERTI FCB, Salviano-Silva A, Beckert HC, de Oliveira KB, et al
    From squamous intraepithelial lesions to cervical cancer: Circulating microRNAs as potential biomarkers in cervical carcinogenesis.
    Biochim Biophys Acta Rev Cancer. 2019 Aug 6. pii: S0304-419X(19)30058.
    Abstract    

    Abstract available

  102. SUN C, Tian X, Liu Z, Li W, et al
    Radiomic analysis for pretreatment prediction of response to neoadjuvant chemotherapy in locally advanced cervical cancer: A multicentre study.
    EBioMedicine. 2019 Aug 5. pii: S2352-3964(19)30491.
    Abstract    

    Abstract available

  103. ADEWUMI K, Oketch SY, Choi Y, Huchko MJ, et al
    Female perspectives on male involvement in a human-papillomavirus-based cervical cancer-screening program in western Kenya.
    BMC Womens Health. 2019;19:107.
    Abstract    

    Abstract available

  104. LAN C, Huan DW, Nie XC, Niu JM, et al
    Association of C8orf4 expression with its methylation status, aberrant beta-catenin expression, and the development of cervical squamous cell carcinoma.
    Medicine (Baltimore). 2019;98:e16715.
    Abstract    

    Abstract available

  105. FUKUI S, Nagasaka K, Iimura N, Kanda R, et al
    Detection of HPV RNA molecules in stratified mucin-producing intraepithelial lesion (SMILE) with concurrent cervical intraepithelial lesion: a case report.
    Virol J. 2019;16:76.
    Abstract    

    Abstract available

  106. WARZECHA D, Szymusik I, Pietrzak B, Kosinska-Kaczynska K, et al
    Sex education in Poland - a cross-sectional study evaluating over twenty thousand polish women's knowledge of reproductive health issues and contraceptive methods.
    BMC Public Health. 2019;19:689.
    Abstract    

    Abstract available

  107. HE J, Yang Y, Chen Z, Liu Y, et al
    Identification of variants and therapeutic epitopes in HPV-33/HPV-58 E6 and E7 in Southwest China.
    Virol J. 2019;16:72.
    Abstract    

    Abstract available

  108. ZHANG C, Cheng W, Liu Q, Guan Q, et al
    Distribution of human papillomavirus infection: a population-based study of cervical samples from Jiangsu Province.
    Virol J. 2019;16:67.
    Abstract    

    Abstract available

  109. ZHU J, Xu J, Jiang LL, Huang JQ, et al
    Improved antitumor activity of cisplatin combined with Ganoderma lucidum polysaccharides in U14 cervical carcinoma-bearing mice.
    Kaohsiung J Med Sci. 2019;35:222-229.
    Abstract    

    Abstract available

  110. SHIMADA C, Todo Y, Yamazaki H, Minobe S, et al
    Cervical laser vaporization for women with cervical intraepithelial neoplasia-3.
    Jpn J Clin Oncol. 2019;49:447-451.
    Abstract    

    Abstract available

  111. ARROSSI S
    [The impact of the HPV test in screening programs in Latin America: The case of Argentina].
    Salud Publica Mex. 2019;61:86-94.
    Abstract    

    Abstract available

  112. LI X, Li J, Jiang Z, Xia L, et al
    Oncological results and recurrent risk factors following abdominal radical trachelectomy: an updated series of 333 patients.
    BJOG. 2019;126:1169-1174.
    Abstract    

    Abstract available

  113. SCHMIDT D
    [Squamous cell precancerous lesions of the cervix uteri].
    Pathologe. 2019;40:7-12.
    Abstract    

    Abstract available

  114. KANSU-CELIK H, Evliyaoglu O, Karakaya BK, Tarlan N, et al
    Two cases of acute urinary retention caused by large cervical leiomyoma with review of literature.
    J Exp Ther Oncol. 2019;13:41-43.
    Abstract    

    Abstract available

  115. ZAGOURI F, Korakiti AM, Zakopoulou R, Kyriazoglou A, et al
    Taxanes during pregnancy in cervical cancer: A systematic review and pooled analysis.
    Cancer Treat Rev. 2019;79:101885.
    Abstract    

    Abstract available

  116. GONG J, Jiang H, Shu C, Hu MQ, et al
    Integrated analysis of circular RNA-associated ceRNA network in cervical cancer: Observational Study.
    Medicine (Baltimore). 2019;98:e16922.
    Abstract    

    Abstract available

  117. ZHU Y, Xie K, Yuan J, Gu B, et al
    Efficacy of oxycodone in intravenous patient-controlled analgesia with different infusion modes after laparoscopic radical surgery of cervical cancer a prospective, randomized, double-blind study.
    Medicine (Baltimore). 2019;98:e16810.
    Abstract    

    Abstract available

  118. MA S, Zhang T, Jiang L, Qin W, et al
    Impact of bladder volume on treatment planning and clinical outcomes of radiotherapy for patients with cervical cancer.
    Cancer Manag Res. 2019;11:7171-7181.
    Abstract    

    Abstract available

  119. TANAKA T, Miyamoto S, Terada S, Kogata Y, et al
    Intraperitoneal cytology after laparoscopic radical hysterectomy with vaginal closure without the use of a manipulator for cervical cancer: a retrospective observational study.
    Cancer Manag Res. 2019;11:7015-7020.
    Abstract    

    Abstract available

  120. LU J, Li X, Tu K, Guan Y, et al
    Verticillin A suppresses HGF-induced migration and invasion via repression of the c-Met/FAK/Src pathway in human gastric and cervical cancer cells.
    Onco Targets Ther. 2019;12:5823-5833.
    Abstract    

    Abstract available

  121. SINGH M, Bhui K, Singh R, Shukla Y, et al
    Retraction notice to "Tea polyphenols enhance cisplatin chemosensitivity in cervical cancer cells via induction of apoptosis" [Life Sci. 93/1 (2013) 7-16].
    Life Sci. 2019 Aug 19:116690. doi: 10.1016/j.lfs.2019.116690.
    Abstract    



  122. WANG T, Sun H, Han F, Sun W, et al
    Evaluation of parametrial infiltration in cervical cancer with voxel-based segmentation of integrated (18)F-FDG PET/MRI images: A preliminary study.
    Eur J Radiol. 2019;118:147-152.
    Abstract    

    Abstract available

  123. GUSTAVSSON I, Aarnio R, Myrnas M, Hedlund-Lindberg J, et al
    Clinical validation of the HPVIR high-risk HPV test on cervical samples according to the international guidelines for human papillomavirus DNA test requirements for cervical cancer screening.
    Virol J. 2019;16:107.
    Abstract    

    Abstract available

  124. SENKOMAGO V, Henley SJ, Thomas CC, Mix JM, et al
    Human Papillomavirus-Attributable Cancers - United States, 2012-2016.
    MMWR Morb Mortal Wkly Rep. 2019;68:724-728.
    Abstract    

    Abstract available

  125. YAHATA H, Sonoda K, Okugawa K, Yagi H, et al
    Survey of the desire to have children and engage in sexual activity after trachelectomy among young Japanese women with early-stage cervical cancer.
    J Obstet Gynaecol Res. 2019 Aug 22. doi: 10.1111/jog.14099.
    Abstract    

    Abstract available

  126. JEROME-D'EMILIA B, Suplee P, Kushary D
    A 10-Year Evaluation of New Jersey's National Breast and Cervical Cancer Early Detection Program: Comparison of Stage at Diagnosis in Enrollees and Nonenrollees.
    J Womens Health (Larchmt). 2019 Aug 22. doi: 10.1089/jwh.2019.7724.
    Abstract    

    Abstract available

  127. XU X, Jiang X, Chen L, Zhao Y, et al
    MiR-181a Promotes Apoptosis and Reduces Cisplatin Resistance by Inhibiting Osteopontin in Cervical Cancer Cells.
    Cancer Biother Radiopharm. 2019 Aug 22. doi: 10.1089/cbr.2019.2858.
    Abstract    

    Abstract available

  128. XIAO L, Hong L, Zheng W
    Motor Neuron and Pancreas Homeobox 1 (MNX1) Is Involved in Promoting Squamous Cervical Cancer Proliferation via Regulating Cyclin E.
    Med Sci Monit. 2019;25:6304-6312.
    Abstract    

    Abstract available

  129. FABIAN D, LaRocco A, Olsen M, Quick A, et al
    Treatment of locally advanced cervical cancer in a patient with a bicornuate uterus with MRI-guided intracavitary/interstitial brachytherapy.
    J Contemp Brachytherapy. 2019;11:285-291.
    Abstract    

    Abstract available

  130. YU CL, Xu XL, Yuan F
    LINC00511 is associated with the malignant status and promotes cell proliferation and motility in cervical cancer.
    Biosci Rep. 2019 Aug 21. pii: BSR20190903. doi: 10.1042/BSR20190903.
    Abstract    

    Abstract available

  131. ZHANG F, Du XM, Huang MN
    [Recurrence pattern and influencing factors of intensity-modulated radiotherapy for cervical cancer].
    Zhonghua Zhong Liu Za Zhi. 2019;41:569-572.
    Abstract    

    Abstract available

  132. CHEN G, Yu X, Zhang M, Zheng A, et al
    Inhibition of Euchromatic Histone Lysine Methyltransferase 2 (EHMT2) Suppresses the Proliferation and Invasion of Cervical Cancer Cells.
    Cytogenet Genome Res. 2019 Aug 22. pii: 000502072. doi: 10.1159/000502072.
    Abstract    

    Abstract available

  133. MOHD-SALLEH SF, Wan-Ibrahim WS, Ismail N
    Pereskia bleo Leaves Extract Induces Cell Death via Cell Cycle Arrest and Apoptosis in Cervical Cancer Cells HeLa.
    Nutr Cancer. 2019 Aug 21:1-9. doi: 10.1080/01635581.2019.1654530.
    Abstract    

    Abstract available

  134. MODI A, Singh M, Gutti G, Shanker OR, et al
    Benzothiazole derivative bearing amide moiety induces p53-mediated apoptosis in HPV16 positive cervical cancer cells.
    Invest New Drugs. 2019 Aug 20. pii: 10.1007/s10637-019-00848.
    Abstract    

    Abstract available

  135. LOU P, Zou S, Shang Z, He C, et al
    RAD18 contributes to the migration and invasion of human cervical cancer cells via the interleukin1beta pathway.
    Mol Med Rep. 2019 Aug 6. doi: 10.3892/mmr.2019.10564.
    Abstract    

    Abstract available

  136. XIE F, Dong D, Du N, Guo L, et al
    An 8gene signature predicts the prognosis of cervical cancer following radiotherapy.
    Mol Med Rep. 2019 Jul 29. doi: 10.3892/mmr.2019.10535.
    Abstract    

    Abstract available

  137. ZHANG H, Xue B, Wang S, Li X, et al
    Long noncoding RNA TP73 antisense RNA 1 facilitates the proliferation and migration of cervical cancer cells via regulating microRNA607/cyclin D2.
    Mol Med Rep. 2019 Aug 8. doi: 10.3892/mmr.2019.10572.
    Abstract    

    Abstract available

  138. CHAO YS, McCormack S, Baezconde-Garbanati L, Agurto I, et al
    Barriers and innovative interventions for early detection of cervical cancer.
    Salud Publica Mex. 2019;61:456-460.
    Abstract    

    Abstract available

  139. LI X, Xiao C, Kong Y, Guo W, et al
    Rectal wall dose-volume effect of pre- or post KUSHEN Ningjiaos relationship with 3D brachytherapy in cervical cancer patients.
    Radiat Oncol. 2019;14:149.
    Abstract    

    Abstract available

  140. DEL MAR DIAZ-GONZALEZ S, Rodriguez-Aguilar ED, Meneses-Acosta A, Valadez-Graham V, et al
    Transregulation of microRNA miR-21 promoter by AP-1 transcription factor in cervical cancer cells.
    Cancer Cell Int. 2019;19:214.
    Abstract    

    Abstract available

  141. AGORASTOS T, Chatzistamatiou K, Tsertanidou A, Mouchtaropoulou E, et al
    Implementation of HPV-based cervical cancer screening combined with self-sampling using a midwifery network across rural Greece. The GRECOSELF study.
    Cancer Prev Res (Phila). 2019 Aug 19. pii: 1940-6207.CAPR-19-0192.
    Abstract    

    Abstract available

  142. TILAHUN T, Tulu T, Dechasa W
    Knowledge, attitude and practice of cervical cancer screening and associated factors amongst female students at Wollega University, western Ethiopia.
    BMC Res Notes. 2019;12:518.
    Abstract    

    Abstract available

  143. JIAO X, Zhang S, Jiao J, Zhang T, et al
    Promoter methylation of SEPT9 as a potential biomarker for early detection of cervical cancer and its overexpression predicts radioresistance.
    Clin Epigenetics. 2019;11:120.
    Abstract    

    Abstract available

  144. GEBREGZIABHER D, Berhanie E, Birhanu T, Tesfamariam K, et al
    Correlates of cervical cancer screening uptake among female under graduate students of Aksum University, College of Health Sciences, Tigray, Ethiopia.
    BMC Res Notes. 2019;12:520.
    Abstract    

    Abstract available

  145. HAN S, Cheng Z, Zhao X, Huang Y, et al
    Diagnostic value of heat shock protein 90alpha and squamous cell carcinoma antigen in detection of cervical cancer.
    J Int Med Res. 2019 Aug 20:300060519865634. doi: 10.1177/0300060519865634.
    Abstract    



  146. WEI X, Zhou Y, Qiu J, Wang X, et al
    Low expression of TUG1 promotes cisplatin sensitivity in cervical cancer by activating the MAPK pathway.
    J BUON. 2019;24:1020-1026.
    Abstract    

    Abstract available

  147. TIAN Q, Wang L, Sun X, Zeng F, et al
    Scopoletin exerts anticancer effects on human cervical cancer cell lines by triggering apoptosis, cell cycle arrest, inhibition of cell invasion and PI3K/AKT signalling pathway.
    J BUON. 2019;24:997-1002.
    Abstract    

    Abstract available

  148. HUANG S, Xie T, Liu W
    Icariin inhibits the growth of human cervical cancer cells by inducing apoptosis and autophagy by targeting mTOR/PI3K/AKT signalling pathway.
    J BUON. 2019;24:990-996.
    Abstract    

    Abstract available

  149. XIAO J, Zhou J, Liang L, Liu F, et al
    Sensitivity of ASPP and P-gp to neoadjuvant chemotherapy combined with gene therapy in locally advanced cervical cancer.
    J BUON. 2019;24:967-974.
    Abstract    

    Abstract available

  150. WOOD B, Taljaard M, El-Khatib Z, McFaul S, et al
    Development and field testing of a tool to elicit women's preferences among cervical cancer screening modalities.
    J Eval Clin Pract. 2019 Aug 18. doi: 10.1111/jep.13258.
    Abstract    

    Abstract available

  151. GONG J, Wang N, Bian L, Wang M, et al
    Cervical cancer evaluated with integrated (18)F-FDG PET/MR.
    Oncol Lett. 2019;18:1815-1823.
    Abstract    

    Abstract available

  152. SONG T, Hou X, Lin B
    MicroRNA-758 inhibits cervical cancer cell proliferation and metastasis by targeting HMGB3 through the WNT/beta-catenin signaling pathway.
    Oncol Lett. 2019;18:1786-1792.
    Abstract    

    Abstract available

  153. WANG S, Gao B, Yang H, Liu X, et al
    MicroRNA-432 is downregulated in cervical cancer and directly targets FN1 to inhibit cell proliferation and invasion.
    Oncol Lett. 2019;18:1475-1482.
    Abstract    

    Abstract available

  154. SHI Q, Xu L, Yang R, Meng Y, et al
    Ki-67 and P16 proteins in cervical cancer and precancerous lesions of young women and the diagnostic value for cervical cancer and precancerous lesions.
    Oncol Lett. 2019;18:1351-1355.
    Abstract    

    Abstract available

  155. LI YJ, Yang Z, Wang YY, Wang Y, et al
    Long non-coding RNA ZNF667-AS1 reduces tumor invasion and metastasis in cervical cancer by counteracting microRNA-93-3p-dependent PEG3 downregulation.
    Mol Oncol. 2019 Aug 17. doi: 10.1002/1878-0261.12565.
    Abstract    

    Abstract available

  156. PRICE CR, Hatch LA, Radisic A, Palakurty SH, et al
    Enhancing Adherence to Cervical Cancer Screening Guidelines at a Student-Run Free Clinic.
    J Community Health. 2019 Aug 16. pii: 10.1007/s10900-019-00724.
    Abstract    

    Abstract available

  157. YANG L, Yang B, Wang Y, Liu T, et al
    The CTIP-mediated repair of TNF-alpha-induced DNA double-strand break was impaired by miR-130b in cervical cancer cell.
    Cell Biochem Funct. 2019 Aug 16. doi: 10.1002/cbf.3430.
    Abstract    

    Abstract available

  158. HE G, Mu T, Yuan Y, Yang W, et al
    Effects of Notch Signaling Pathway in Cervical Cancer by Curcumin Mediated Photodynamic Therapy and Its Possible Mechanisms in Vitro and in Vivo.
    J Cancer. 2019;10:4114-4122.
    Abstract    

    Abstract available

  159. LIU X, Meng Q, Wang W, Zhou Z, et al
    Predictors of Distant Metastasis in Patients with Cervical Cancer Treated with Definitive Radiotherapy.
    J Cancer. 2019;10:3967-3974.
    Abstract    

    Abstract available

  160. FU J, Wang W, Wang Y, Liu C, et al
    The role of squamous cell carcinoma antigen (SCC Ag) in outcome prediction after concurrent chemoradiotherapy and treatment decisions for patients with cervical cancer.
    Radiat Oncol. 2019;14:146.
    Abstract    

    Abstract available

  161. MAJ C, Poncet L, Panjo H, Gautier A, et al
    General practitioners who never perform Pap smear: the medical offer and the socio-economic context around their office could limit their involvement in cervical cancer screening.
    BMC Fam Pract. 2019;20:114.
    Abstract    

    Abstract available

  162. LIU WN, Shi J, Fu Y, Zhao XH, et al
    The Stability and Activity Changes of Apigenin and Luteolin in Human Cervical Cancer Hela Cells in Response to Heat Treatment and Fe(2+)/Cu(2+) Addition.
    Foods. 2019;8.
    Abstract    

    Abstract available

  163. CAO Y, Min J, Zheng D, Li J, et al
    Vehicle-saving theranostic probes based on hydrophobic iron oxide nanoclusters using doxorubicin as a phase transfer agent for MRI and chemotherapy.
    Chem Commun (Camb). 2019;55:9015-9018.
    Abstract    

    Abstract available

  164. DE SANJOSE S, Delany-Moretlwe S
    HPV vaccines can be the hallmark of cancer prevention.
    Lancet. 2019 Jun 26. pii: S0140-6736(19)30549.
    Abstract    



  165. LI D, Xu XX, Yan DD, Yuan SH, et al
    [Clinical significance of serum squamous cell carcinoma antigen in patients with early cervical squamous cell carcinoma].
    Zhonghua Zhong Liu Za Zhi. 2019;41:357-362.
    Abstract    

    Abstract available

  166. SEO SS, Oh HY, Kim MK, Lee DO, et al
    Combined Effect of Secondhand Smoking and Alcohol Drinking on Risk of Persistent Human Papillomavirus Infection.
    Biomed Res Int. 2019;2019:5829676.
    Abstract    

    Abstract available

  167. JAAFARI-ASHKVANDI Z, Shirazi SY, Rezaeifard S, Hamedi A, et al
    Cytotoxic Effects of Pistacia Atlantica (Baneh) Fruit Extract on Human KB Cancer Cell Line.
    Acta Medica (Hradec Kralove). 2019;62:30-34.
    Abstract    

    Abstract available

  168. PYKE RM, Genolet R, Harari A, Coukos G, et al
    Computational KIR copy number discovery reveals interaction between inhibitory receptor burden and survival.
    Pac Symp Biocomput. 2019;24:148-159.
    Abstract    

    Abstract available

  169. HAMMER A, Kahlert J, Gravitt PE, Rositch AF, et al
    Authors' response: Higher cervical cancer mortality among older women in Denmark could be due to insufficient screening coverage.
    Acta Obstet Gynecol Scand. 2019 Aug 21. doi: 10.1111/aogs.13710.
    Abstract    

    Abstract available

  170. LECAVALIER-BARSOUM M, Chaudary N, Han K, Pintilie M, et al
    Correction: Targeting CXCL12/CXCR4 and myeloid cells to improve the therapeutic ratio in patient-derived cervical cancer models treated with radio-chemotherapy.
    Br J Cancer. 2019 Aug 9. pii: 10.1038/s41416-019-0545.
    Abstract    

    Abstract available

  171. D'ALESSANDRO P, Giudicepietro A, Della Corte L, Arduino B, et al
    A case of gastric-type mucinous endocervical adenocarcinoma in presence of nabothian cysts.
    Eur J Obstet Gynecol Reprod Biol. 2019;236:254-255.
    Abstract    



  172. DIAZ-FEIJOO B, Temprana-Salvador J, Franco-Camps S, Manrique S, et al
    Clinical management of early-stage cervical cancer: The role of sentinel lymph node biopsy in tumors </=2cm.
    Eur J Obstet Gynecol Reprod Biol. 2019;241:30-34.
    Abstract    

    Abstract available

  173. KIM SI, Lee M, Lee S, Suh DH, et al
    Impact of laparoscopic radical hysterectomy on survival outcome in patients with FIGO stage IB cervical cancer: A matching study of two institutional hospitals in Korea.
    Gynecol Oncol. 2019 Aug 2. pii: S0090-8258(19)31408.
    Abstract    

    Abstract available

  174. ENGLISH DP, Huang M
    Highlights from the Society of Gynecologic Oncology's 50th Annual Meeting on Women's Cancer.
    Gynecol Oncol. 2019 Apr 22. pii: S0090-8258(19)31150.
    Abstract    



  175. HORSBOEL TA, Kjaer SK, Johansen C, Suppli NP, et al
    Increased risk for depression persists for years among women treated for gynecological cancers - a register-based cohort study with up to 19years of follow-up.
    Gynecol Oncol. 2019 Apr 8. pii: S0090-8258(19)30494.
    Abstract    

    Abstract available

  176. HARPER DM, Nieminen P, Donders G, Einstein MH, et al
    The efficacy and safety of Tipapkinogen Sovacivec therapeutic HPV vaccine in cervical intraepithelial neoplasia grades 2 and 3: Randomized controlled phase II trial with 2.5years of follow-up.
    Gynecol Oncol. 2019 Apr 2. pii: S0090-8258(19)30484.
    Abstract    

    Abstract available

  177. GUAN Y, Luan Y, Xie Y, Zhou H, et al
    Chloride channel-3 is required for efficient tumour cell migration and invasion in human cervical squamous cell carcinoma.
    Gynecol Oncol. 2019;153:661-669.
    Abstract    

    Abstract available

  178. SHUKLA V, Varghese VK, Kabekkodu SP, Mallya S, et al
    Enumeration of deregulated miRNAs in liquid and tissue biopsies of cervical cancer.
    Gynecol Oncol. 2019 Aug 18. pii: S0090-8258(19)31463.
    Abstract    

    Abstract available

  179. BIANCHI A, Lopez S, Altwerger G, Bellone S, et al
    PARP-1 activity (PAR) determines the sensitivity of cervical cancer to olaparib.
    Gynecol Oncol. 2019 Aug 18. pii: S0090-8258(19)31461.
    Abstract    

    Abstract available

  180. SWAILES AL, Hossler CE, Kesterson JP
    Pathway to the Papanicolaou smear: The development of cervical cytology in twentieth-century America and implications in the present day.
    Gynecol Oncol. 2019 Apr 14. pii: S0090-8258(19)30499.
    Abstract    

    Abstract available

  181. VINK FJ, Meijer CJLM, Clifford GM, Poljak M, et al
    FAM19A4/miR124-2 methylation in invasive cervical cancer: A retrospective cross-sectional worldwide study.
    Int J Cancer. 2019 Aug 7. doi: 10.1002/ijc.32614.
    Abstract    

    Abstract available

  182. POLMAN NJ, Veldhuijzen NJ, Heideman DAM, Snijders PJF, et al
    Management of HPV-Positive Women in Cervical Screening Using Results from Two Consecutive Screening Rounds.
    Int J Cancer. 2018 Nov 22. doi: 10.1002/ijc.32004.
    Abstract    

    Abstract available

  183. BAO C, Yang R, Pedersen NL, Xu W, et al
    Overweight in midlife and risk of cancer in late life: A nationwide Swedish twin study.
    Int J Cancer. 2019;144:2128-2134.
    Abstract    

    Abstract available

  184. PIMENOFF VN, Tous S, Benavente Y, Alemany L, et al
    Distinct geographic clustering of oncogenic human papillomaviruses multiple infections in cervical cancers: results from a worldwide cross-sectional study.
    Int J Cancer. 2018 Nov 2. doi: 10.1002/ijc.31964.
    Abstract    

    Abstract available

  185. QUERLEU D, Leblanc E
    Combined vaginal and laparoscopic approach for the surgical management of cervical cancer: a historic note.
    Int J Gynecol Cancer. 2019 Jul 27. pii: ijgc-2019-000750.
    Abstract    



  186. SIMONDS H, Botha MH, Ellmann A, Warwick J, et al
    HIV status does not have an impact on positron emission tomography-computed tomography (PET-CT) findings or radiotherapy treatment recommendations in patients with locally advanced cervical cancer.
    Int J Gynecol Cancer. 2019 Aug 13. pii: ijgc-2019-000641.
    Abstract    

    Abstract available

  187. BOGANI G, Vinti D, Murgia F, Chiappa V, et al
    Burden of lymphatic disease predicts efficacy of adjuvant radiation and chemotherapy in FIGO 2018 stage IIICp cervical cancer.
    Int J Gynecol Cancer. 2019 Aug 17. pii: ijgc-2019-000669.
    Abstract    

    Abstract available

  188. CAO L, Wen H, Feng Z, Han X, et al
    Distinctive clinicopathologic characteristics and prognosis for different histologic subtypes of early cervical cancer.
    Int J Gynecol Cancer. 2019 Aug 17. pii: ijgc-2019-000556.
    Abstract    

    Abstract available

  189. WARD K, Ramzan A, Sheeder J, Fischer S, et al
    Persistent opioid use after radiation therapy in opioid-naive cervical cancer survivors.
    Int J Gynecol Cancer. 2019 Aug 15. pii: ijgc-2019-000430.
    Abstract    

    Abstract available

  190. DATTA NR, Stutz E, Gomez S, Bodis S, et al
    Efficacy and Safety Evaluation of the Various Therapeutic Options in Locally Advanced Cervix Cancer: A Systematic Review and Network Meta-Analysis of Randomized Clinical Trials.
    Int J Radiat Oncol Biol Phys. 2019;103:411-437.
    Abstract    

    Abstract available

  191. BRUCE SF, Joshi TV, Chervoneva I, Yi M, et al
    Disparities Among Cervical Cancer Patients Receiving Brachytherapy.
    Obstet Gynecol. 2019 Aug 7. doi: 10.1097/AOG.0000000000003401.
    Abstract    

    Abstract available

  192. DAI B, Yu R, Fan M, Yang T, et al
    HMQTF2 suppresses migration of the human cervical cancer HeLa cells by reversing EMT via the PI3K/Akt signaling pathway.
    Oncol Rep. 2019 Jul 23. doi: 10.3892/or.2019.7245.
    Abstract    

    Abstract available

  193. AEDO-AGUILERA V, Carrillo-Beltran D, Calaf GM, Munoz JP, et al
    Curcumin decreases epithelialmesenchymal transition by a Pirindependent mechanism in cervical cancer cells.
    Oncol Rep. 2019 Aug 21. doi: 10.3892/or.2019.7288.
    Abstract    

    Abstract available

  194. NAM KH, Yi SA, Nam G, Noh JS, et al
    Identification of a novel S6K1 inhibitor, rosmarinic acid methyl ester, for treating cisplatin-resistant cervical cancer.
    BMC Cancer. 2019;19:773.
    Abstract    

    Abstract available

  195. ARFI A, Hequet D, Bataillon G, Tran-Perennou C, et al
    HPV DNA integration site as proof of the origin of ovarian metastasis from endocervical adenocarcinoma: three case reports.
    BMC Cancer. 2019;19:375.
    Abstract    

    Abstract available

  196. YANG WT, Zhao ZX, Li B, Zheng PS, et al
    NF-YA transcriptionally activates the expression of SOX2 in cervical cancer stem cells.
    PLoS One. 2019;14:e0215494.
    Abstract    

    Abstract available

  197. MOODLEY J, Scott SE, Mwaka AD, Constant D, et al
    Development and validation of the African Women Awareness of CANcer (AWACAN) tool for breast and cervical cancer.
    PLoS One. 2019;14:e0220545.
    Abstract    

    Abstract available

  198. BENSKI AC, Viviano M, Jinoro J, Alec M, et al
    HPV self-testing for primary cervical cancer screening in Madagascar: VIA/VILI triage compliance in HPV-positive women.
    PLoS One. 2019;14:e0220632.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;